Enhancement of CHO bioreactor performance has typically been derived from optimization of media formulations and feeding strategies, with advances in clone selection systems and cell engineering also playing an essential role. However, these breakthroughs in media development are usually not disclosed by the biopharmaceutical industry or media vendors due to commercial considerations. As a result, optimisation of CHO culture performance from the research sector is thus limited and timeconsuming with undesired and/or unexpected effects in essential steps (e. g. transfection) also observed. To address this deficit in information, in-house serum-free and chemically-defined media (SFM and CDM) were developed as working tools to study the effect...
peer-reviewedSingle‐use technologies, in particular disposable bioreactor bags, have become integral...
Chinese hamster ovary (CHO) cells are the dominant host for producing biotherapeutic proteins. Despi...
To improve the cost of producing protein therapeutics manufacturers can attempt to increase the amou...
Enhancement of CHO bioreactor performance has typically been derived from optimization of media form...
Chinese hamster ovary (CHO) cells are among the most commonly used mammalian cell lines for the prod...
Chinese Hamster Ovary (CHO) cells are the most common mammalian cell line used around the world and ...
Continual growth in the biopharmaceutical industry in recombinant protein production has resulted in...
Mammalian cells especially Chinese Hamster Ovary (CHO) cells have been the dominating production pla...
Mammalian cell cultures have become a universal path for producing therapeutic proteins, monoclonal ...
University of Minnesota Ph.D. dissertation. June 2014. Major: Chemical Engineering. Advisor: Profess...
Cell culture medium plays a critical role on mammalian cell growth, protein expression and quality. ...
As the world population continues to grow and age, access to medical therapies, like therapeutic mon...
The biopharmaceutical industry utilizes Chinese Hamster Ovary (CHO) cells for the production of reco...
The selection of CHO cell lines for manufacturing therapeutic proteins involves multiple screening s...
Biologic drugs, or large molecule drugs, such as monoclonal antibodies, are proteins that are manufa...
peer-reviewedSingle‐use technologies, in particular disposable bioreactor bags, have become integral...
Chinese hamster ovary (CHO) cells are the dominant host for producing biotherapeutic proteins. Despi...
To improve the cost of producing protein therapeutics manufacturers can attempt to increase the amou...
Enhancement of CHO bioreactor performance has typically been derived from optimization of media form...
Chinese hamster ovary (CHO) cells are among the most commonly used mammalian cell lines for the prod...
Chinese Hamster Ovary (CHO) cells are the most common mammalian cell line used around the world and ...
Continual growth in the biopharmaceutical industry in recombinant protein production has resulted in...
Mammalian cells especially Chinese Hamster Ovary (CHO) cells have been the dominating production pla...
Mammalian cell cultures have become a universal path for producing therapeutic proteins, monoclonal ...
University of Minnesota Ph.D. dissertation. June 2014. Major: Chemical Engineering. Advisor: Profess...
Cell culture medium plays a critical role on mammalian cell growth, protein expression and quality. ...
As the world population continues to grow and age, access to medical therapies, like therapeutic mon...
The biopharmaceutical industry utilizes Chinese Hamster Ovary (CHO) cells for the production of reco...
The selection of CHO cell lines for manufacturing therapeutic proteins involves multiple screening s...
Biologic drugs, or large molecule drugs, such as monoclonal antibodies, are proteins that are manufa...
peer-reviewedSingle‐use technologies, in particular disposable bioreactor bags, have become integral...
Chinese hamster ovary (CHO) cells are the dominant host for producing biotherapeutic proteins. Despi...
To improve the cost of producing protein therapeutics manufacturers can attempt to increase the amou...